Related Experiment Video
Updated: Jul 17, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cell therapy in myocardial infarction
Sara D Collins1, Richard Baffour, Ron Waksman
1Department of Internal Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
Insights
Cell therapy shows promise for heart failure by replacing damaged heart tissue. However, early clinical trial results are inconsistent, indicating further research is needed for this potential treatment.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Heart failure presents significant morbidity and mortality.
- Current treatments may not halt adverse myocardial remodeling.
- Cell therapy offers a potential strategy to repair damaged heart muscle.
Purpose of the Study:
- To review the current state of cell therapy for heart failure.
- To explore proposed mechanisms of action for cell-based treatments.
- To assess the clinical efficacy and future directions of cell therapy in heart failure.
Main Methods:
- Review of existing literature on cell therapy in heart failure models.
- Analysis of various stem cell types (e.g., bone marrow-derived stem cells, skeletal myoblasts).
- Examination of different delivery routes and proposed therapeutic mechanisms (transdifferentiation, fusion, paracrine effects).
Main Results:
- Multiple stem cell types and delivery methods have been investigated.
- Proposed mechanisms include cell replacement, fusion, and paracrine signaling.
- Early promising clinical results have not been consistently replicated in larger studies.
Conclusions:
- Cell therapy holds theoretical potential for treating heart failure.
- The precise mechanisms of benefit require further elucidation.
- Robust clinical evidence is lacking, necessitating more research before widespread adoption.
Abstract:
Heart failure is associated with a high rate of morbidity and mortality. In some patients, current treatment modalities may not be adequate to prevent myocardial remodeling, which leads to exacerbation of the disease. Cell therapy is based on the premise of replacing damaged myocardium with functional tissues. Multiple forms of stem cells, including bone marrow-derived stem cells and skeletal myoblasts, have been investigated using several delivery routes of administration. Different mechanisms have been proposed to explain the beneficial effects of cell-based therapy. These include cell transdifferentiation, cell fusion, and release of paracrine growth factors. The beneficial effects of cell therapy may involve multiple mechanisms. The encouraging results of early clinical cell therapy studies have not been sustained by subsequent robust studies. These findings suggest that many unanswered questions need to be addressed before cell therapy becomes an acceptable adjunctive treatment for heart failure.
Related Concept Videos
01:14Myocarditis III: Medical Management
01:21Myocarditis I: Introduction
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:29Cardiomyopathy V: Interprofessional Care